Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

COST Action 'ImpARAS': what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101576043 Publication Model: eCollection Cited Medium: Print ISSN: 2045-7022 (Print) Linking ISSN: 20457022 NLM ISO Abbreviation: Clin Transl Allergy Subsets: PubMed not MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central
    • Abstract:
      The growing world population and increased pressure on agricultural resources are driving a shortage of dietary protein sources. As a result, industry is developing more sustainable novel food protein sources such as insects, algae and duckweed and using new processing techniques. Consumer exposure to these novel or processed proteins, could cause new food allergies, exacerbating a public health issue which is already directly affecting an estimated 20 million Europeans. Introduction of novel foods should not add to the burden of food allergy and this calls for a reliable, harmonised, evidence-based and validated allergenicity risk assessment strategy. The COST (Cooperation in Science and Technology) Action ImpARAS (Improved Allergenicity Risk Assessment Strategy), a four-year networking project, identified gaps in current allergy risk assessment, and proposed new ideas and plans for improving it. Here, we report on the lessons learned from the ImpARAS network and suggestions for future research. The safe introduction of novel and more sustainable food protein sources, while protecting humans from food allergy, calls for a multidisciplinary approach based on an improved understanding of what determines the relative allergenic potency of proteins, novel testing and assessment methodologies, harmonized decision-making criteria, and a clear ranking approach to express the allergenicity of novel product relative to that of existing known allergenic proteins: (from 'non'/to weakly and to strongly allergenic proteins).
      (© The Author(s) 2020.)
    • References:
      J Allergy Clin Immunol. 2018 Jan;141(1):41-58. (PMID: 29157945)
      J Allergy Clin Immunol. 2017 Aug;140(2):600-603.e7. (PMID: 28274747)
      Mol Nutr Food Res. 2018 Jan;62(1):. (PMID: 28925060)
      Clin Transl Allergy. 2016 Jun 16;6:21. (PMID: 27313841)
      Regul Toxicol Pharmacol. 2016 Aug;79:118-124. (PMID: 27012375)
      Allergy. 2012 Aug;67(8):1023-32. (PMID: 22737987)
      Toxicol Lett. 2016 Nov 16;262:62-69. (PMID: 27663974)
    • Contributed Indexing:
      Keywords: Allergy risk assessment; Decision-making criteria; Food allergy; de novo sensitisation
    • Publication Date:
      Date Created: 20200602 Latest Revision: 20200604
    • Publication Date:
      20200716
    • Accession Number:
      PMC7236523
    • Accession Number:
      10.1186/s13601-020-00318-x
    • Accession Number:
      32477491
  • Citations
    • ABNT:
      VERHOECKX, K. et al. COST Action “ImpARAS”: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium. Clinical and translational allergy, [s. l.], v. 10, p. 13, 2020. DOI 10.1186/s13601-020-00318-x. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=32477491&custid=s8280428. Acesso em: 4 ago. 2020.
    • AMA:
      Verhoeckx K, Lindholm Bøgh K, Constable A, et al. COST Action “ImpARAS”: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium. Clinical and translational allergy. 2020;10:13. doi:10.1186/s13601-020-00318-x.
    • AMA11:
      Verhoeckx K, Lindholm Bøgh K, Constable A, et al. COST Action “ImpARAS”: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium. Clinical and translational allergy. 2020;10:13. doi:10.1186/s13601-020-00318-x
    • APA:
      Verhoeckx, K., Lindholm Bøgh, K., Constable, A., Epstein, M. M., Hoffmann Sommergruber, K., Holzhauser, T., Houben, G., Kuehn, A., Roggen, E., O’Mahony, L., Remington, B., & Crevel, R. (2020). COST Action “ImpARAS”: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium. Clinical and Translational Allergy, 10, 13. https://doi.org/10.1186/s13601-020-00318-x
    • Chicago/Turabian: Author-Date:
      Verhoeckx, Kitty, Katrine Lindholm Bøgh, Anne Constable, Michelle M Epstein, Karin Hoffmann Sommergruber, Thomas Holzhauser, Geert Houben, et al. 2020. “COST Action ‘ImpARAS’: What Have We Learnt to Improve Food Allergy Risk Assessment. A Summary of a 4 Year Networking Consortium.” Clinical and Translational Allergy 10 (May): 13. doi:10.1186/s13601-020-00318-x.
    • Harvard:
      Verhoeckx, K. et al. (2020) ‘COST Action “ImpARAS”: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium’, Clinical and translational allergy, 10, p. 13. doi: 10.1186/s13601-020-00318-x.
    • Harvard: Australian:
      Verhoeckx, K, Lindholm Bøgh, K, Constable, A, Epstein, MM, Hoffmann Sommergruber, K, Holzhauser, T, Houben, G, Kuehn, A, Roggen, E, O’Mahony, L, Remington, B & Crevel, R 2020, ‘COST Action “ImpARAS”: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium’, Clinical and translational allergy, vol. 10, p. 13, viewed 4 August 2020, .
    • MLA:
      Verhoeckx, Kitty, et al. “COST Action ‘ImpARAS’: What Have We Learnt to Improve Food Allergy Risk Assessment. A Summary of a 4 Year Networking Consortium.” Clinical and Translational Allergy, vol. 10, May 2020, p. 13. EBSCOhost, doi:10.1186/s13601-020-00318-x.
    • Chicago/Turabian: Humanities:
      Verhoeckx, Kitty, Katrine Lindholm Bøgh, Anne Constable, Michelle M Epstein, Karin Hoffmann Sommergruber, Thomas Holzhauser, Geert Houben, et al. “COST Action ‘ImpARAS’: What Have We Learnt to Improve Food Allergy Risk Assessment. A Summary of a 4 Year Networking Consortium.” Clinical and Translational Allergy 10 (May 18, 2020): 13. doi:10.1186/s13601-020-00318-x.
    • Vancouver/ICMJE:
      Verhoeckx K, Lindholm Bøgh K, Constable A, Epstein MM, Hoffmann Sommergruber K, Holzhauser T, et al. COST Action “ImpARAS”: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium. Clinical and translational allergy [Internet]. 2020 May 18 [cited 2020 Aug 4];10:13. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=32477491&custid=s8280428